The effect of Tangzhiping on insulin sensitivity and inflammatory factors in patients with metabolic syndrome

Hui ZHOU,Yanbin GAO

DOI: https://doi.org/10.3969/j.issn.2095-6606.2015.03.004

2015-01-01

Abstract:Objective To observe the effect of Tangzhiping on insulin sensitivity, high sensitive C reactive protein ( hs-CRP ) and tumor necrosis factor-α( TNF-α) in patients with metabolic syndrome ( MS) .Methods 70 MS patients who met with defined criteria were randomly divided into treatment group (n=35) and control group (n=35).Besides the original treatment,Tangzhiping and rosiglitazone were given to the treatment group and control group separately for 12 weeks.Insulin action index ( IAI) , insulin resistance index ( IRI ) , hs-CRP and TNF-αwere observed before and after treatment in two groups.Results There were 65 patients fulfilled this trial, among which 33 were treated with Tangzhiping, and 32 were treated with rosiglitazone.IAI were all increased significantly in two groups than those before treatment(P <0.01).There was no statistical significance between two groups(P>0.05).IR were all decreased in both groups than those before treatment ( P<0.01).There was no statistical significance between two groups(P>0.05).The levels of hs-CRP were all higher than the reference value in two groups before treatment.The level of hs-CRP were all decreased in two groups than those before treatment ( P<0 .01 ) , but there was no statistical significance between two groups ( P>0.05).The level of TNF-αwere all decreased in two groups than those before treatment (P<0.01), but there was no statistical significance between two groups( P >0.05).Conclusions Tangzhiping could improve insulin sensitivity of patient with MS.It could also decrease the levels of hs-CRP and TNF-α.